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Abstract
Objectives To evaluate the effectiveness of pre-hospital adrenaline
(epinephrine) administered by emergency medical services to patients
with out of hospital cardiac arrest.
Design Controlled propensity matched retrospective cohort study, in
which pairs of patients with or without (control) adrenaline were created
with a sequential risk set matching based on time dependent propensity
score.
Setting Japan’s nationwide registry database of patients with out of
hospital cardiac arrest registered between January 2007 and December
2010.
Participants Among patients aged 15-94 with out of hospital cardiac
arrest witnessed by a bystander, we created 1990 pairs of patients with
and without adrenaline with an initial rhythm of ventricular fibrillation or
pulseless ventricular tachycardia (VF/VT) and 9058 pairs among those
with non-VF/VT.
Main outcome measures Overall and neurologically intact survival at
one month or at discharge, whichever was earlier.
Results After propensity matching, pre-hospital administration of
adrenaline by emergency medical services was associated with a higher
proportion of overall survival (17.0% v 13.4%; unadjusted odds ratio
1.34, 95% confidence interval 1.12 to 1.60) but not with neurologically
intact survival (6.6% v 6.6%; 1.01, 0.78 to 1.30) among those with VF/VT;
and higher proportions of overall survival (4.0% v 2.4%; odds ratio 1.72,
1.45 to 2.04) and neurologically intact survival (0.7% v 0.4%; 1.57, 1.04
to 2.37) among those with non-VF/VT.
Conclusions Pre-hospital administration of adrenaline by emergency
medical services improves the long term outcome in patients with out
of hospital cardiac arrest, although the absolute increase of neurologically
intact survival was minimal.
Introduction
Pre-hospital cardiopulmonary resuscitation for patients with out
of hospital cardiac arrest commonly includes administration of
adrenaline (epinephrine) by emergencymedical services. Despite
extensive research on its effectiveness, there is no definite
evidence to support its routine use. Whether pre-hospital use of
adrenaline improves long term prognoses remains uncertain,
although it unequivocally increases return of spontaneous
circulation.1 2 Recent randomised controlled trials showed
slightly favourable (but non-significant) effects of pre-hospital
adrenaline in improving long term survival,3 4 whereas
observational studies have not indicated any significant
favourable effects and some large scale registry based studies
have even shown detrimental long term effects.5-10
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These contradictory results could come from methodological
shortcomings. The randomised controlled trials were
underpowered. The observational studies could not adjust for
time dependent imbalance of severity: timing of return of
spontaneous circulation is a determinant of both outcome and
treatment (those who rapidly respond to initial resuscitation
procedures would have a higher chance of survival and a lower
chance of being given of adrenaline).2 6 11 12A few registry based
studies have focused on timing and shown favourable effects
of early administration, but they did not adjust for the timing
of return of spontaneous circulation.11 13 In addition, previous
studies ignored possible use of adrenaline in hospital; without
this information, evaluation of pharmacological effects of
adrenaline is impossible.
Evaluation of the effectiveness of the strategy of using
pre-hospital adrenaline in improving long term outcomes in
patients with out of hospital cardiac arrest would contribute to
resolving the uncertainty about the role of adrenaline in
pre-hospital resuscitation.2 We analysed a large scale national
database in Japan, which provided sufficient power to detect
any small effects, and used time dependent propensity score
matching to adjust for the time dependent imbalance in patients
inherent in observational studies.
Methods
Study settings
In Japan, the fire departments of municipal governments are
responsible for emergency medical services, dispatching
ambulances from fire stations. Each ambulance team consists
of three emergencymedical services personnel, usually including
at least one emergency lifesaving technician trained to provide
advanced life support (advanced airwaymanagement, placement
of intravenous line, and defibrillation). Ambulances with doctors
are also available but are not routinely used.14 Emergency
lifesaving technicians certified after training in hospital are
allowed to administer adrenaline (epinephrine) and perform
endotracheal intubation with remote instruction from a doctor.
Administration of adrenaline to patients with out of hospital
cardiac arrest by emergency lifesaving technicians started in
April 2006 with a small number of certified technicians, which
gradually increased. Thus, during the study period Japanese
emergencymedical services consisted of amixture of ambulance
teams with and without the ability to administer pre-hospital
adrenaline (a relatively small fraction of patients with out of
hospital cardiac arrest received pre-hospital adrenaline), which
allowed us to examine the effectiveness of pre-hospital
adrenaline administered by emergency medical services. The
emergency medical services resuscitation procedures follow
Japanese guidelines for cardiopulmonary resuscitation, based
on the American Heart Association guidelines current at that
time. If patients with out of hospital cardiac arrest do not respond
to initial cardiopulmonary resuscitation and defibrillation, a
dose of 1 mg intravenous adrenaline can be given under
instruction from a doctor (other routes or other drugs are not
permitted). Repeated doses can be given. Emergency medical
services have no discretion to stop resuscitation at the scene;
they are supposed to resuscitate and transport patients with out
of hospital cardiac arrest to hospital if they are not definitely
dead (in cases of decapitation and torso transection, for
example). Details have been described elsewhere.10 11 14 15
Study design
We used a controlled propensity matched retrospective cohort
study to compare outcome in patients who received (adrenaline
group) or did not receive (control group) pre-hospital adrenaline
by emergency medical services. We used national registry data
obtained from the All-Japan Utstein Registry of patients with
out of hospital cardiac arrest. We restricted our comparison to
pre-hospital use of adrenaline because the registry data did not
include information on use in hospital. We could assume that
almost all of the patients reaching the hospital without return
of spontaneous circulation received adrenaline at the hospital.11 16
We adopted time dependent propensity score matching to assure
comparability between adrenaline and control groups by
balancing severity of the cardiac arrest and characteristics of
the patients (see table 1⇓) at each time interval (every minute
from 6 to 30 minutes) from initiation of cardiopulmonary
resuscitation by emergency medical services to administration
of adrenaline.17 All the analyses including propensity score
calculation and outcome comparison were performed separately
among those with an initial rhythm of ventricular fibrillation or
pulseless ventricular tachycardia (VF/VT) and among those
with non-VF/VT, because the initial rhythms definitively
determine the cardiopulmonary resuscitation procedures and
prognoses.
Study participants
We included patients aged 15-94 who had an out of hospital
cardiac arrest witnessed by a bystander and were registered
between January 2007 and December 2010 (figure⇓). In some
cases with no witness, cardiopulmonary resuscitation might
have been not indicated but still carried out so we excluded
them because emergency medical services have no discretion
to terminate resuscitation. We also excluded patients who
arrested after the arrival of emergency medical services (as we
focused on cardiac arrest in situations without medical
personnel), those who were given adrenaline after return of
spontaneous circulation (re-arrest cases), those in whom arrest
was attributable to external causes (such as trauma, drowning,
poisoning, and asphyxia), and those with missing, contradictory,
or outlying data (such as negative or long (>2 hours) response
interval). We also excluded those who were transported by
ambulance without an emergency lifesaving technician or by
ambulance with doctors.
Data collection and variables
Since 2005, the All-Japan Utstein Registry, a national registry
managed by the Fire andDisasterManagement Agency of Japan,
has prospectively registered all patients with out of hospital
cardiac arrest transported to hospital by emergency medical
services in Japan.15 Emergency medical services staff collected
data using an Utstein-style form,18 including age, sex, initial
rhythm (VF/VT, pulseless electrical activity, asystole, and
other), presumed cause of arrest, witnessed or not, description
of bystander (family member, colleague, and other), bystander
cardiopulmonary resuscitation including defibrillation with an
automated external defibrillator, instruction in cardiopulmonary
resuscitation to bystander by staff at emergencymedical services
control centre, activities of emergency medical services
(defibrillation, airwaymanagement, intravenous line placement,
administration of adrenaline), time course of activities (timing
of the first dose of adrenaline was recorded; timings of additional
doses, airway management, and placement of intravenous line
were not recorded), and patient outcomes (spontaneous return
of circulation before admission to hospital and long term
survival). Failed attempts at airway management or intravenous
line placement were not recorded. Information on treatment and
return of spontaneous circulation after arrival at hospital was
also not recorded. Intravenous line placement was not included
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in any analyses because it is a part of adrenaline administration
procedures. Adrenaline doses were recorded but not included
in the analyses because total doses were unknown without
information on doses in hospital. If patients reached hospital
without return of spontaneous circulation, control patients might
have received adrenaline and patients in the adrenaline group
might have received additional doses.11 16
The timings of activities of emergency medical services were
measured with a clock synchronised within the emergency
medical services system, recorded on the activity log forms,
and then transcribed to the Utstein-style form. One of the three
crew members took charge of data recording; they were trained
to record and report the activities with the timing using the
designated forms. The physician treating the patient at the
hospital determined the cause of arrest clinically. Emergency
medical services staff in charge of the data collection contacted
the physician to seek information on survival and neurological
function at one month or at discharge, whichever was earlier.
If the patient survived, the physician assessed neurological
function using the Glasgow-Pittsburgh cerebral performance
category score: 1 (good), 2 (moderately disabled), 3 (severely
disabled), 4 (vegetative state), or 5 (dead).18
The fire departments sent the data to the Fire and Disaster
Management Agency, where they were compiled.14 The agency
checked the data for missing or contradictory values and
requested the fire departments to correct any errors detected to
assure the data quality. Of the witnessed patients (n=144 074),
3636 (2.5%) hadmissing timing data; of those otherwise eligible
for the analyses (n=100 677), 4598 (4.6%) had contradictory,
outlying, or missing data in the variables that were used for
propensity score calculation (figure⇓).
In this study, patients administered adrenaline were defined as
those with data on timing of administration; patients without
such data were categorised as not receiving adrenaline. We
assumed that this categorisation would underestimate rather
than overestimate the effects of pre-hospital use of adrenaline
and would lead to conservative results. Some patients who
actually received adrenaline might have lacked data on timing.
Time dependent propensity score matching
Time dependent propensity score matching is a sequential risk
set matching that uses time dependent propensity scores. We
created pairs of adrenaline and control patients (1:1 matching)
within a risk set at each time interval from the start of
cardiopulmonary resuscitation by emergency medical services
in a chronological order.17 19 The risk set at time t consisted of
those who are at risk of treatment at time t, excluding those who
have attained return of spontaneous circulation (no indication
of treatment by emergencymedical services) or reached hospital
(no possibility of treatment by emergency medical services) by
time t. The sequential matching should not depend on future
information to avoid selection biases. Therefore, patient who
later received adrenaline as well as those who never received it
were included in the risk set and could be selected as controls
(a control group consisting of patients who never received
adrenaline alone would accumulate those with favourable
outcomes because patients who were slow to attain return of
spontaneous circulationmight have received adrenaline whereas
those who attained return of spontaneous circulation relatively
early would not).17 19
The time dependent propensity scores were predicted values,
denoted by S, in the following Cox proportional hazard model:
h(t)=h0(t)exp(b1x1+b2x2+b3x3+...+bpxp),
S=b1x1+b2x2+b3x3+...+bpxp
where h(t) and h0(t) are the hazard function and corresponding
baseline hazard function, respectively, which are both constants
for given t; t was the time interval from the start of
cardiopulmonary resuscitation by emergency medical services
to administration of adrenaline by emergency medical services;
and b1, b2, b3, ... bp and x1, x2, x3, ... xpwere estimated coefficients
and covariates, respectively.
The model included all the variables obtainable in the field as
predictors, except for the description of the bystander (family
member or not), which violated the proportionality assumption,
and the time from the onset of cardiopulmonary resuscitation
by emergency medical services to defibrillation, which caused
multicollinearity. The predictors, categorised in table 1⇓, were
year, sex, age, bystander cardiopulmonary resuscitation,
bystander defibrillation, cardiopulmonary resuscitation
instruction given, initial rhythm, time interval from call to
emergency medical services to patient contact, number of
attempts at defibrillation by emergency medical services, and
advanced airway management. The model also included
prefecture categories according to the proportions of patients
with out-of-hospital cardiac arrest witnessed by a bystander
who received adrenaline by emergency medical services (four
categories: <5%, 5-<15%, 15-<30%, and ≥30%) to adjust for
regionally different environments influencing pre-hospital use
of adrenaline.
We created pairs having the closest propensity scores within a
calliper (in each pair, the difference in the propensity scores
should be within this predetermined width), a quarter of the
standard deviation of the propensity scores, without replacement,
using a user developed psmatch2 program in Stata,20 as described
by Guo and Fraser.21 In the matching process, the timing of
administration of adrenaline from the start of cardiopulmonary
resuscitation by emergency medical services for the matching
was restricted from t=6 to t=30 (minutes); administration at t<6
was considered to be technically difficult and administration at
t>30 was rare. The matched pairs were removed from the
subsequent procedures. The matching created 1990 pairs for
VT/VF and 9058 pairs for non-VF/VT patients.
We showed the imbalance between groups of patients using
differences of proportions as all variables were categorical
(appendix 1). We used imbalance proportion defined as the sum
of absolute differences of proportions between groups among
all levels (categories) in each variable and using standardised
difference of proportions defined as
√(P1−P2)′∑
−1(P1−P2)
where a (k−1) dimensional proportion vector P1−P2 in a variable
with k levels is considered to approximately follow (k−1)
dimensional normal distribution
Nk−1(0,∑)
Here, P1 and P2 are (k−1) dimensional proportion vectors of a
variable with k levels in VF/VT and non-VF/VT groups,
respectively. ∑ is a (k−1) dimensional diagonal matrix with the
(i,i) element being variance of the i-th element (i=1,2,...,k−1)
of the proportion vector P1−P2.
Endpoints
The endpoints were overall survival and neurologically intact
survival with the Glasgow-Pittsburgh cerebral performance
category score 1-2 at one month or at discharge, whichever was
earlier. Most of the previous studies used survival at one month
or at discharge with and without neurological outcomes, which
allowed us to compare our findings with the previous ones.
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Statistical analysis
After describing the participants’ characteristics (before and
after matching), we applied conditional logistic regression
models to the matched pairs, with and without adjustment for
the variables that were not included in the development of the
propensity score, to determine the relation between
administration of adrenaline and the endpoints. As the outcomes
were measured only once at a fixed time point (at one month
or discharge), we did not use a Cox proportional hazard model
for the outcome comparisons. The covariates for adjustment in
the logistic regression models were bystander description, time
from the onset of cardiopulmonary resuscitation by emergency
medical services to hospital arrival, time from the onset of
cardiopulmonary resuscitation by emergency medical services
to the first defibrillation, and presumed cause of arrest. As the
sample sizes were determined by the number of patients
registered in the database, we calculated the power of the Wald
tests of the parameters being equal to 0 (null hypothesis) under
a significance level of 5% (two sided).22 All analyses were
performed with Stata version 12.1 (StataCorp, College Station,
TX, USA).
Results
Patients’ characteristics
Of the 438 005 patients aged 15-94 with out of hospital cardiac
arrest registered in the database during the study period, 96 079
met the inclusion criteria (figure⇓). Pre-hospital adrenaline
(epinephrine) was administered in 16.5% of those with VF/VT
(14 943) and 13.5% of those with non-VF/VT (81 136). The
proportions of overall survival and neurologically intact survival
at one month or at discharge were 7.7% and 3.9%, respectively,
among all patients; 26.8% and 17.6%, respectively, among those
with VF/VT; and 4.2% and 1.3%, respectively, among those
with non-VF/VT.
Among all patients, administration of adrenaline increased year
by year during the study period regardless of the initial rhythm
(table 1⇓). Those who received adrenaline tended to have
received cardiopulmonary resuscitation from a bystander after
instruction, had advanced airway management, had a long
interval from call to emergency medical services to patient
contact, and had multiple defibrillations, delayed defibrillation,
delayed hospital arrival, and delayed return of spontaneous
circulation.
The propensity score matching balanced the distribution of each
variable included in the propensity score calculation, with the
imbalance proportions varying from 0.1-50.5% in VF/VT and
0.4-50.9% in non-VF/VT patients before matching and
decreasing to 0.10-6.6% and 0.04-3.4%, respectively, after
matching; the standardised differences between groups
decreasing from 0.02-16.9 in VF/VT and 0.21-34.8 in
non-VF/VT patients to 0.02-2.63 and 0.02-3.98, respectively
(tables 1 and 2⇓).
Main results
In the matched samples, the adrenaline treated groups showed
higher proportions of overall survival at one month or at
discharge than the control groups in both VF/VT (17.0% v
13.4%, 3.6 percentage points difference) and non-VF/VT
patients (4.0% v 2.4%, 1.6 percentage points difference) (table
2⇓). The proportion of patients with neurologically intact
survival did not differ between adrenaline and control groups
in VF/VT patients (6.6% v 6.6%); it was higher in the adrenaline
group among non-VF/VT patients (0.7% v 0.4%, 0.2 percentage
point difference).
For VF/VT patients, overall survival was significantly associated
with administration of adrenaline (unadjusted odds ratio 1.34
(95% confidence interval 1.12 to 1.60); adjusted odds ratio 1.36
(1.13 to 1.63)); whereas neurologically intact survival was not
associated with use of adrenaline (unadjusted odds ratio 1.01,
0.78 to 1.30; adjusted odds ratio 1.02, 0.78 to 1.33) (table 3⇓).
For non-VF/VT patients, overall survival was also significantly
associated with use of adrenaline (unadjusted odds ratio 1.72
(1.45 to 2.04), adjusted odds ratio 1.78 (1.49 to 2.13)). For
neurologically intact survival, the unadjusted odds ratio was
significant at 1.57 (1.04 to 2.37), but the adjusted odds ratio
was not significant (1.55, 0.99 to 2.41). The powers of theWald
tests exceeded 80% for the analyses of overall survival, and
equalled 50% for that of neurologically intact survival among
those with non-VF/VT.
Discussion
Patients who have a cardiac arrest out of hospital and who are
given adrenaline (epinephrine) by emergency medical services
have more favourable long term outcomes than those not given
adrenaline. With adjustment for the time dependent patient
imbalance, the present study resolves the uncertainty about the
role of pre-hospital adrenaline. Though the overall proportion
of patients who survived was higher in the adrenaline group
than in the control group, however, neurologically intact survival
was similar.
Strengths and limitations
Our study was sufficiently powered and successfully adjusted
for time dependent severity of cardiac arrest, using sequential
risk set matching with time dependent propensity scores (in
other words, it adjusted for the varying duration of resuscitation
procedures).2 This way, for those who received adrenaline at a
certain time point, their controls were selected from those who
were, at that time point, still at risk for adrenaline use and had
similar propensity scores (similar likelihood of receiving
adrenaline).17 19 Some variables used in calculating propensity
scores (such as age, time before arrival of emergency medical
services, rhythms) were also related to the likelihood of being
successfully resuscitated, resulting in somewhat similar
likelihood of successful resuscitation between the two groups
as far as the involved variables were concerned. Without this
adjustment, severely affected patients who required longer
resuscitation procedures would tend to accumulate in the group
treated with adrenaline.
Several limitations should be noted. Firstly, the database did
not include information on the treatment in hospital. Without
knowing the in hospital and total doses of adrenaline, we could
not evaluate the pharmacological effects of adrenaline but could
compare only the strategies with and without pre-hospital
adrenaline using information on the timing of the first
pre-hospital doses. Nevertheless, in terms of the survival
outcomes, the timing of the first dose matters11 13 but the total
of the doses might not.23 Furthermore, as we did not have
information on care after resuscitation, which obviously
influences the outcomes,24 we could not adjust for confounding
from differences between hospitals; however, we believe the
confounding effects were minimal because hospital abilities are
unlikely to influence the decision to use pre-hospital adrenaline.11
Secondly, the database did not record information on treatment
decisions (when, how, and why what decisions were made) or
failed attempts at treatment but recorded only actual treatment.
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Some treatment decisions to give adrenaline might not have
been executed because of return of spontaneous circulation
before the treatment or failed placement of an intravenous line.
Discrepancies between the decisions and the actual treatment
might have caused some biases, although we tried to obtain the
best estimate of the effects of adrenaline by fully using available
information.
Thirdly, unmeasured factors that influence both treatment
decisions and patient outcomes might have confounded the
results; the magnitude of their influences could not be quantified.
For example, short distance to the hospital could be a
determinant of both good outcomes and quick transfer of patients
without pre-hospital adrenaline25; existence of comorbidities
and their severities might also have influenced both the decisions
and the outcomes.
Fourthly, improved overall survival might have resulted from
improved performance of resuscitation by emergency lifesaving
technicians certified for adrenaline administration because they
had additional training. We could not adjust for the skills of
emergency lifesaving technicians as we had no information on
certification status and quality of resuscitation. Records of these
factors (in hospital treatment, treatment decision, failed attempts
at treatment, distance to hospital, and certification status) would
allow us to reduce confounding and achieve better balance.
Comparison with other studies
Our findings contradict the harmful long term effects of
adrenaline shown in previous observational studies, including
a recent Japanese study that used the same database.9 10Hagihara
and colleagues used propensity score matching and logistic
regression to adjust for confounding and showed that
pre-hospital administration of adrenaline might reduce the
chances of overall and neurologically intact survival at one
month by about 50% and 80%, respectively.10 Their statistical
models including only time independent covariates, however,
could not appropriately adjust for time dependent imbalance.
Other studies using large scale registry data in Japan were able
to partially address the time dependent imbalance. Hayashi and
colleagues13 using a local registry (Osaka Utstein registry) and
Nakahara and colleagues11 using the national registry adjusted
for the timing of administration of adrenaline in amanner similar
to the present study but somewhat imprecisely. Both showed
favourable effects of early administration. They could not,
however, adjust for the timing of return of spontaneous
circulation and hospital arrival among the control group,
important determinants of both adrenaline administration and
outcomes, for which we fully adjusted on a minute by minute
basis. Our findings could be explained by the timing of
treatment: administration by emergency medical services
minimises the interval before the patients receives adrenaline.
The contrasting findings with the same data result from different
analytical methods of adjustment for important confounding.
Similarly contrasting findings resulted from the same
randomised controlled trial data in Norway that used different
analytical methods: per-protocol analysis showed that actual
adrenaline use was associated with decreased survival to
discharge contrary to the original results with intention to treat
analysis.3 12Categorisation of patients based on actual treatment
caused imbalance of severity of the cardiac arrest: less severely
affected patients tended to attain return of spontaneous
circulation before adrenaline administration in the intervention
group.
Meaning of the study
The present findings that pre-hospital administration of
adrenaline by emergencymedical services resulted in favourable
survival outcomes do not simply support the expansion of such
strategies. Strategies of pre-hospital adrenaline given by
emergency medical services might mainly increase survival
with severe neurological disabilities among those with VF/VT
and minimally increase neurologically intact survival among
those with non-VF/VT. To determine the role of routine use of
pre-hospital adrenaline, further studies are required to evaluate
whether adrenaline really disproportionately increases disabled
survival, and societal debate would then be required on the issue
of such a potential increase of severely disabled survival.
In determining the role of adrenaline, we also have to consider
the effects of post-resuscitation care such as hypothermia, which
has been shown to improve long term neurological
outcomes.24 26-28 Improved post-resuscitation care might have
the potential to modify the effects of adrenaline and to increase
neurologically intact survival among those with VF/VT after
administration. Increasing overall survival is the prerequisite
of increasing neurologically intact survival.
Theminimal absolute difference of neurologically intact survival
between adrenaline and control groups (0.3 percentage point)
among those with non-VF/VT reflected the extremely poor
prognoses of these patients. Although the small absolute
difference suggests a minimal impact of pre-hospital use of
adrenaline in the population, adrenaline might be considered as
the last resort after other interventions fail if there is the slightest
possibility of increasing survival.
Showing the effectiveness of strategies that use pre-hospital
adrenaline in improving outcomes of patients with out of
hospital cardiac arrest, despite continued uncertainty about
whether the improvement resulted from pre-hospital adrenaline
use or additional training to emergency lifesaving technicians,
would contribute to consolidating the weakest link of the “chain
of survival,” the fourth link: early access to advanced life
support including drug use.29 Our findings provide evidence
supporting the benefit of streamlining the fourth link; this would
ease the dilemma that emergency lifesaving technicians have
faced (“What if our treatment is doing some harm to the
patient?”) as there had been no such evidence up to the present.
Generalisability
The present results might not generalise to other countries,
although the generalisability to the whole population of patients
with out of hospital cardiac arrest witnessed by a bystander in
Japan can be guaranteed as all such patients are registered in
the national registry. Pre-hospital care systems, including
termination rules and hospital capacities for post-arrest care,
vary from country to country, which could modify the effects
of adrenaline. Our findings cannot be generalised to cases with
no witness or witnessed by emergency medical services; such
cases were excluded from our analyses. Therefore, previously
and newly collected data in other countries should be analysed
to appropriately handle time dependent patient imbalance.
Conclusions
Our study showed some favourable effects of pre-hospital
administration of adrenaline by emergency medical services on
long term outcomes of patients with out of hospital cardiac
arrest after we accounted for time dependent patient imbalances,
which previous observational studies had not fully addressed.
The absolute increase of neurologically intact survival, however,
was minimal. Previous observational data could be reanalysed
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with the methods we used. The registry of out of hospital cardiac
arrest should collect more information (such as comorbidities,
post-resuscitation care, abilities of emergency lifesaving
technician, and hospital treatment) to more accurately evaluate
the effectiveness of pre-hospital use of adrenaline. Furthermore,
to determine the efficacy of adrenaline in resuscitation, large
scale randomised controlled trials might be needed.
Part of this study was presented at the Kanto regional meeting of
Japanese Association for Acute Medicine, in Tokyo, Japan, 28 February
2013.
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What is already known on this topic
Early access to emergency medical care, cardiopulmonary resuscitation, and defibrillation have clear benefit on survival after out of
hospital cardiac arrest
Whether pre-hospital use of adrenaline improves long term prognoses after out of hospital cardiac arrest remains uncertain, although
it unequivocally increases return of spontaneous circulation
Some observational studies have shown harmful effects of pre-hospital adrenaline, whereas recent randomised controlled trials have
shown slightly favourable (non-significant) effects
What this study adds
There were some favourable long term outcomes among patients with out of hospital cardiac arrest who received pre-hospital adrenaline
from emergency medical services
The overall survival proportion was higher among those who received adrenaline than those who did not, but neurologically intact survival
was similar
This study accounted for time dependent patient imbalance, which previous observational studies had not done
Tables
Table 1| Characteristics, outcomes, and imbalance indicators of patients with witnessed out of hospital cardiac arrest by initial rhythms
and pre-hospital administration of adrenaline (epinephrine) before propensity score matching. Figures are numbers (percentages) unless
stated otherwise
Non-VF/VT (n=81 136)VF/VT (n=14 943)
Patient
imbalance
%IP (D)*
Adrenaline (n=10
957)
No adrenaline (n=70
179)
Patient
imbalance
%IP (D)*Adrenaline (n=2464)
No adrenaline (n=12
479)
Year:
30.5 (13.6)1477 (13.5)17 628 (25.1)27.5 (5.80)363 (14.7)3208 (25.7)2007
2364 (21.6)17 665 (25.2)568 (23.1)3220 (25.8)2008
3050 (27.8)16 923 (24.1)655 (26.6)2989 (24.0)2009
4066 (37.1)17 963 (25.6)878 (35.6)3062 (24.5)2010
Proportion of adrenaline use in prefecture (%):
40.8 (32.6)160 (1.5)4857 (6.9)37.6 (14.0)44 (1.8)900 (7.2)<5
4216 (38.5)37 501 (53.4)947 (38.4)6464 (51.8)5-<15
6191 (56.5)26 960 (38.4)1403 (56.9)4988 (40.0)15-<30
390 (3.6)861 (1.2)70 (2.8)127 (1.0)≥30
7.7 (6.05)6801 (62.1)40 854 (58.2)10.5 (5.71)2055 (83.4)9751 (78.1)Male
Age (years):
7.2 (2.59)334 (3.0)2440 (3.5)2.7 (0.87)258 (10.5)1308 (10.5)<45
1693 (15.5)10 174 (14.5)824 (33.4)4308 (34.5)45-64
2327 (21.2)13 474 (19.2)657 (26.7)3180 (25.5)65-74
3862 (35.2)24 308 (34.6)522 (21.2)2622 (21.0)75-84
2741 (25.0)19 783 (28.2)203 (8.2)1061 (8.5)≥85
4.0 (2.71)5241 (47.8)32 156 (45.8)1.9 (0.60)1233 (50.0)6361 (51.0)CPR by bystander
0.4 (0.21)123 (1.1)637 (0.9)0.1 (0.02)56 (2.3)278 (2.2)AED by bystander
8.9 (5.93)5224 (47.7)30 349 (43.2)10.0 (3.13)1178 (47.8)5339 (42.8)CPR instruction
Airway management:
50.9 (34.8)3062 (27.9)37 254 (53.1)50.5 (16.9)774 (31.4)7068 (56.6)Bag valve mask
724 (6.6)4839 (6.9)163 (6.6)793 (6.4)Laryngeal mask
airway
5112 (46.7)22 860 (32.6)1145 (46.5)3933 (31.5)Oesophageal
obturator airway
2059 (18.8)5226 (7.4)382 (15.5)685 (5.5)Tracheal intubation
No of attempts at defibrillation:
10.0 (16.4)9884 (90.2)66 810 (95.2)39.8 (11.9)66 (2.7)530 (4.2)0
806 (7.4)2896 (4.1)1170 (47.5)8215 (65.8)1-2
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Table 1 (continued)
Non-VF/VT (n=81 136)VF/VT (n=14 943)
Patient
imbalance
%IP (D)*
Adrenaline (n=10
957)
No adrenaline (n=70
179)
Patient
imbalance
%IP (D)*Adrenaline (n=2464)
No adrenaline (n=12
479)
267 (2.4)473 (0.7)1228 (49.8)3734 (29.9)≥3
EMS call-contact interval (min):
13.2 (6.33)2421 (22.1)19 125 (27.3)18.0 (5.14)673 (27.3)4531 (36.3)≤6
3036 (27.7)20 452 (29.1)796 (32.3)3743 (30.0)7-8
2473 (22.6)14 456 (20.6)513 (20.8)2304 (18.5)9-10
3027 (27.6)16 146 (23.0)482 (19.6)1901 (15.2)≥11
—7431 (67.8)43 643 (62.2)—2288 (92.9)11 283 (90.4)Arrest had cardiac
origin
—7661 (69.9)48 888† (69.7)—1542 (62.6)7573 (60.7)Family member was
bystander
CPR (EMS)-defibrillation interval (min):
—9884 (90.2)66 810 (95.2)—66 (2.7)530 (4.2)No defibrillation
—49 (0.4)322 (0.5)—1480 (60.1)7389 (59.2)1-2
—85 (0.8)402 (0.6)—670 (27.2)3330 (26.7)3-4
—938‡ (8.6)2645 (3.8)—248 (10.1)1230 (9.9)≥5
CPR (EMS)-hospital arrival interval (min):
—910 (8.3)22 259 (31.7)—221 (9.0)4182 (33.5)≤17
—2149 (19.6)17 523 (25.0)—502 (20.4)3246 (26.0)18-22
—3565 (32.5)16 974 (24.2)—821 (33.3)2900 (23.2)23-29
—4333 (39.5)13 423 (19.1)—920 (37.3)2151 (17.2)≥30
CPR (EMS)-ROSC interval (min):
—8929 (81.5)66 194 (94.3)—1932 (78.4)8975 (71.9)No ROSC
—12 (0.1)1800 (2.6)—10 (0.4)1596 (12.8)≤6
—288 (2.6)1144 (1.6)—102 (4.1)1228 (9.8)7-12
—947 (8.6)760 (1.1)—268 (10.9)566 (4.5)13-21
—781 (7.1)281 (0.4)—152 (6.2)114 (0.9)≥22
Outcomes:
—428§ (3.9)2963 (4.2)—406 (16.5)3594 (28.8)Overall survival
—67 (0.6)1023 (1.5)—169 (6.9)2466 (19.8)Neurologically intact
survival (CPC 1-2)
VF⁄VT=ventricular fibrillation or ventricular tachycardia; EMS=emergency medical service; CPR=cardiopulmonary resuscitation; AED=automated external defibrillator;
ROSC=return of spontaneous circulation; CPC=Glasgow-Pittsburgh cerebral performance category score.
*Variables included in propensity score development show imbalance indicators. IP denotes imbalance proportion defined by sum of absolute differences of
proportions between groups among all levels in each variable. D denotes standardised difference defined as √(P1−P2)′∑
−1(P1−P2), where (k−1) dimensional proportion
vector P1−P2 in variable with k levels is considered to follow (k−1) dimensional normal distribution Nk−1 (0,∑). Here, P1 and P2 are (k−1) dimensional proportion
vectors of variable with k levels in VF/VT and non-VF/VT groups, respectively. ∑ is (k−1) dimensional diagonal matrix with (i,i) element being variance of i-th
element (i=1,2,...,k−1) of proportion vector P1−P2.
†Data missing in two patients.
‡Data missing in one patient.
§Data missing in one patient.
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Table 2| Characteristics, outcomes, and imbalance indicators of patients with witnessed out of hospital cardiac arrest by initial rhythms
and pre-hospital administration of adrenaline (epinephrine) after propensity score matching. Figures are numbers (percentages) unless
stated otherwise
Non-VF/VT (n=18 116)VF/VT (n=3980)
Patient
imbalance%IP
(D)*Adrenaline (n=9058)
No adrenaline
(n=9058)
Patient
imbalance
%IP (D)*Adrenaline (n=1990)
No adrenaline
(n=1990)
Year:
1.5 (0.45)1271 (14.0)1216 (13.4)2.4 (0.39)305 (15.3)312 (15.7)2007
1995 (22.0)1999 (22.1)463 (23.3)480 (24.1)2008
2520 (27.8)2509 (27.7)520 (26.1)509 (25.6)2009
3272 (36.1)3334 (36.8)702 (35.3)689 (34.6)2010
Proportion of adrenaline use in prefecture (%):
1.8 (0.93)146 (1.6)119 (1.3)3.4 (0.77)43 (2.2)29 (1.5)<5
3625 (40.0)3606 (39.8)814 (40.9)817 (41.1)5-<15
5001 (55.2)5081 (56.1)1077 (54.1)1108 (55.7)15-<30
286 (3.2)252 (2.8)56 (2.8)36 (1.8)≥30
0.5 (0.26)5622 (62.1)5600 (61.8)6.6 (2.63)1642 (82.5)1708 (85.8)Male
Age (years):
1.2 (0.37)278 (3.1)243 (2.7)4.0 (0.65)200 (10.1)200 (10.1)<45
1397 (15.4)1379 (15.2)674 (33.9)695 (34.9)45-64
1908 (21.1)1929 (21.3)526 (26.4)545 (27.4)65-74
3204 (35.4)3217 (35.5)422 (21.2)402 (20.2)75-84
2271 (25.1)2290 (25.3)168 (8.4)148 (7.4)≥85
0.04 (0.02)4273 (47.2)4275 (47.2)0.1 (0.02)985 (49.5)984 (49.4)CPR by bystander
0.7 (0.22)105 (1.2)75 (0.8)1.7 (0.27)45 (2.3)28 (1.4)AED by bystander
0.5 (0.23)4288 (47.3)4310 (47.6)1.6 (0.35)927 (46.6)943 (47.4)CPR instruction
Airway management:
1.4 (0.61)2695 (29.8)2676 (29.5)4.6 (0.89)663 (33.3)704 (35.4)Bag valve mask
616 (6.8)572 (6.3)137 (6.9)114 (5.7)Laryngeal mask
airway
4182 (46.2)4229 (46.7)904 (45.4)909 (45.7)Oesophageal
obturator airway
1565 (17.3)1581 (17.5)286 (14.4)263 (13.2)Tracheal intubation
No of attempts at defibrillation:
3.4 (3.98)8214 (90.7)8368 (92.4)2.0 (0.35)54 (2.7)34 (1.7)0
637 (7.0)558 (6.2)978 (49.1)984 (49.4)1-2
207 (2.3)132 (1.5)958 (48.1)972 (48.8)≥3
EMS call-contact interval (min):
0.4 (0.13)2075 (22.9)2069 (22.8)2.5 (0.48)561 (28.2)578 (29.0)≤6
2539 (28.0)2547 (28.1)634 (31.9)642 (32.3)7-8
2046 (22.6)2034 (22.5)419 (21.1)401 (20.2)9-10
2398 (26.5)2408 (26.6)376 (18.9)369 (18.5)≥11
—6151 (67.9)5820 (64.3)—1854 (93.2)1828 (91.9)Arrest had cardiac
origin
—6324 (69.8)6507† (71.8)—1233 (62.0)1312 (65.9)Family member was
bystander
CPR (EMS)-defibrillation interval (min):
—8214 (90.7)8368 (92.4)—54 (2.7)34(1.7)No defibrillation
—35 (0.4)44 (0.5)—1193 (59.9)1191 (59.8)1-2
—65 (0.7)65 (0.7)—542 (27.2)535 (26.9)3-4
—743 (8.2)581 (6.4)—201 (10.1)230 (11.6)≥5
CPR (EMS)-hospital arrival interval (min):
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Table 2 (continued)
Non-VF/VT (n=18 116)VF/VT (n=3980)
Patient
imbalance%IP
(D)*Adrenaline (n=9058)
No adrenaline
(n=9058)
Patient
imbalance
%IP (D)*Adrenaline (n=1990)
No adrenaline
(n=1990)
—785 (8.7)1092 (12.1)—190 (9.5)260 (13.1)≤17
—1850 (20.4)1965 (21.7)—419 (21.1)463 (23.3)18-22
—3110 (34.3)2902 (32.0)—673 (33.8)651 (32.7)23-29
—3313 (36.6)3099 (34.2)—708 (35.6)616 (31.0)≥30
Outcomes:
—363‡ (4.0)214 (2.4)—338 (17.0)267 (13.4)Overall survival
—59 (0.7)38 (0.4)—132 (6.6)131 (6.6)Neurologically intact
survival (CPC 1-2)
VF⁄VT=ventricular fibrillation or ventricular tachycardia; EMS=emergency medical service; CPR=cardiopulmonary resuscitation; AED=automated external defibrillator;
ROSC=return of spontaneous circulation; CPC=Glasgow-Pittsburgh cerebral performance category score.
*Variables included in propensity score development show imbalance indicators. IP denotes imbalance proportion defined by sum of absolute differences of
proportions between groups among all levels in each variable. D denotes standardised difference defined as √(P1−P2)′∑
−1(P1−P2), where (k−1) dimensional proportion
vector P1−P2 in variable with k levels is considered to follow (k−1) dimensional normal distribution Nk−1 (0,∑). Here, P1 and P2 are (k−1) dimensional proportion
vectors of variable with k levels in VF/VT and non-VF/VT groups, respectively. ∑ is (k−1) dimensional diagonal matrix with (i,i) element being variance of i-th
element (i=1,2,...,k−1) of proportion vector P1−P2.
†Data missing in one patient.
‡Data missing in one patient.
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Table 3| Logistic regression analyses among matched patients. Odds ratios for comparison between patients with out of hospital cardiac
arrest who received pre-hospital adrenaline (epinephrine) administered by emergency medical services and controls
Odds ratio (95% CI)
Adjusted†Unadjusted*
Ventricular fibrillation/ventricular tachycardia
1.36 (1.13 to 1.63)1.34 (1.12 to 1.60)‡Overall survival
1.02 (0.78 to 1.33)1.01 (0.78 to 1.30)§Neurologically intact survival
Non-ventricular fibrillation/ventricular tachycardia
1.78 (1.49 to 2.13)1.72 (1.45 to 2.04)¶Overall survival
1.55 (0.99 to 2.41)1.57 (1.04 to 2.37)**Neurologically intact survival
*Bivariate analysis after propensity score matching.
†Adjusted for presumed cause (cardiac/non-cardiac origin), time from onset of CPR by emergency medical services to hospital arrival, and type of bystander
(family/non-family), and time from onset of CPR to first defibrillation with multivariate logistic regression model.
‡Power=0.87.
§Power not calculated because OR was nearly 1.
¶Power >0.99.
**Power=0.50.
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Figure
Selection of cases for study of effect of pre-hospital administration of adrenaline (epinephrine) in patients with out of hospital
cardiac arrest. EMS=emergency medical service; ROSC=return of spontaneous circulation; ELST=emergency lifesaving
technician
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